Sarissa Capital is an investment firm that focuses on the healthcare sector, particularly in biotechnology and pharmaceuticals. The company leverages deep industry expertise to make investments in innovative companies with the potential to create significant value.

Sarissa Capital Management was founded by Alex Denner, Ph.D., in 2013 to capitalize on compelling opportunities for constructive shareholder activism within the healthcare sector. Sarissa's team of subject matter experts and philosophy of thoughtful engagement aims to create positive outcomes for investors, shareholders and patients by taking an owner-oriented approach to their investments.  Sarissa seeks to optimize healthcare companies so they can efficiently provide important medicines to society and increase the impact of medical innovation, while also generating value to shareholders.

Pear Therapeutics

Iterum Therapeutics

Sarissa Capital Management LP

Amarin Announces Preliminary Voting Results
https://lnkd.in/eJ6QnmHX

Press Release Dated February 28, 2023- Sarissa Capital Wins Proxy Contest Against Amarin By Huge Landslide #FreeAmarin

COM:SARISSACAP

Sarissa Capital

Analysis Not Available